tiprankstipranks
Trending News
More News >
Benitec Biopharma Ltd (BNTC)
NASDAQ:BNTC
US Market
Advertisement

Benitec Biopharma (BNTC) Ratios

Compare
298 Followers

Benitec Biopharma Ratios

BNTC's free cash flow for Q4 2025 was AU$0.50. For the 2025 fiscal year, BNTC's free cash flow was decreased by AU$ and operating cash flow was AU$-33.71. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
54.67 10.49 0.94 1.90 15.05
Quick Ratio
54.67 10.49 0.93 1.90 15.05
Cash Ratio
54.24 10.33 0.62 1.60 14.44
Solvency Ratio
-16.51 -4.31 -4.50 -5.88 -9.76
Operating Cash Flow Ratio
-13.09 -3.94 -4.53 -6.28 -9.37
Short-Term Operating Cash Flow Coverage
-66.63 -68.32 0.00 0.00 0.00
Net Current Asset Value
AU$ 96.22MAU$ 46.71MAU$ -533.00KAU$ 1.73MAU$ 19.24M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 0.13 0.14 <0.01
Debt-to-Equity Ratio
<0.01 <0.01 2.77 0.28 0.01
Debt-to-Capital Ratio
<0.01 <0.01 0.73 0.22 0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.02 1.11 22.10 2.07 1.07
Debt Service Coverage Ratio
-117.98 -73.20 -566.76 -569.00 -2.25K
Interest Coverage Ratio
0.00 0.00 -578.21 -557.94 -2.27K
Debt to Market Cap
<0.01 <0.01 0.00 0.00 0.00
Interest Debt Per Share
0.02 0.03 0.21 0.88 0.43
Net Debt to EBITDA
2.32 2.36 0.10 0.18 1.44
Profitability Margins
Gross Profit Margin
0.00%50.00%-408.00%87.67%-108.47%
EBIT Margin
-7511.69%-10069.91%-25441.33%-24898.63%-23518.64%
EBITDA Margin
-7511.69%-9911.11%-24933.33%-24457.53%-23044.07%
Operating Profit Margin
-7511.69%-10412.04%-25441.33%-24457.53%-23044.07%
Pretax Profit Margin
-6819.60%-10069.91%-26082.67%-24942.47%-23528.81%
Net Profit Margin
-6819.60%-10069.91%-26082.67%-25427.40%-23357.63%
Continuous Operations Profit Margin
-6819.60%-10069.91%-26082.67%-24942.47%-23528.81%
Net Income Per EBT
100.00%100.00%100.00%101.94%99.27%
EBT Per EBIT
90.79%96.71%102.52%101.98%102.10%
Return on Assets (ROA)
-38.07%-41.66%-438.22%-310.77%-64.46%
Return on Equity (ROE)
-45.28%-46.04%-9684.16%-644.07%-68.87%
Return on Capital Employed (ROCE)
-42.71%-47.56%-3926.13%-518.86%-67.95%
Return on Invested Capital (ROIC)
-42.40%-45.66%-2507.74%-492.85%-66.74%
Return on Tangible Assets
-38.07%-41.66%-438.22%-310.77%-64.46%
Earnings Yield
-7.43%-29.20%-173.84%-97.91%-37.74%
Efficiency Ratios
Receivables Turnover
16.85 0.94 0.00 24.33 2.36
Payables Turnover
0.54 0.08 0.33 0.02 0.45
Inventory Turnover
0.00 0.00 29.31 5.00K 0.00
Fixed Asset Turnover
0.56 0.48 0.12 0.07 0.10
Asset Turnover
<0.01 <0.01 0.02 0.01 <0.01
Working Capital Turnover Ratio
<0.01 <0.01 0.07 <0.01 <0.01
Cash Conversion Cycle
-649.25 -4.18K -1.08K -17.10K -658.43
Days of Sales Outstanding
21.66 386.97 0.00 15.00 154.66
Days of Inventory Outstanding
0.00 0.00 12.45 0.07 0.00
Days of Payables Outstanding
670.92 4.57K 1.09K 17.11K 813.09
Operating Cycle
21.66 386.97 12.45 15.07 154.66
Cash Flow Ratios
Operating Cash Flow Per Share
-0.65 -1.89 -6.50 -16.54 -25.39
Free Cash Flow Per Share
-0.65 -1.91 -6.50 -16.55 -25.83
CapEx Per Share
<0.01 0.02 <0.01 0.01 0.44
Free Cash Flow to Operating Cash Flow
1.00 1.01 1.00 1.00 1.02
Dividend Paid and CapEx Coverage Ratio
-3.93K -108.40 -18.01K -1.22K -58.06
Capital Expenditure Coverage Ratio
-3.93K -108.40 -18.01K -1.22K -58.06
Operating Cash Flow Coverage Ratio
-27.78 -68.32 -32.22 -19.60 -60.24
Operating Cash Flow to Sales Ratio
-42.42 -89.83 -240.16 -217.79 -217.49
Free Cash Flow Yield
-6.38%-26.29%-160.08%-83.93%-35.75%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-13.46 -3.43 -0.58 -1.02 -2.65
Price-to-Sales (P/S) Ratio
665.23 344.90 150.04 259.70 618.83
Price-to-Book (P/B) Ratio
5.24 1.58 55.71 6.58 1.82
Price-to-Free Cash Flow (P/FCF) Ratio
-15.68 -3.80 -0.62 -1.19 -2.80
Price-to-Operating Cash Flow Ratio
-21.63 -3.84 -0.62 -1.19 -2.85
Price-to-Earnings Growth (PEG) Ratio
-0.66 0.04 <0.01 0.03 0.04
Price-to-Fair Value
5.24 1.58 55.71 6.58 1.82
Enterprise Value Multiple
-6.54 -1.12 -0.50 -0.88 -1.25
Enterprise Value
272.97M 23.92M 9.33M 15.71M 16.95M
EV to EBITDA
-6.54 -1.12 -0.50 -0.88 -1.25
EV to Sales
490.96 110.72 124.46 215.17 287.37
EV to Free Cash Flow
-11.57 -1.22 -0.52 -0.99 -1.30
EV to Operating Cash Flow
-11.57 -1.23 -0.52 -0.99 -1.32
Tangible Book Value Per Share
2.69 4.60 0.07 3.00 39.60
Shareholders’ Equity Per Share
2.69 4.60 0.07 3.00 39.60
Tax and Other Ratios
Effective Tax Rate
0.00 0.03 >-0.01 -0.02 <0.01
Revenue Per Share
0.02 0.02 0.03 0.08 0.12
Net Income Per Share
-1.05 -2.12 -7.06 -19.31 -27.27
Tax Burden
1.00 1.00 1.00 1.02 0.99
Interest Burden
0.91 1.00 1.03 1.00 1.00
Research & Development to Revenue
32.97 72.26 170.32 154.41 118.98
SG&A to Revenue
42.15 31.07 85.09 91.04 110.37
Stock-Based Compensation to Revenue
31.34 3.84 6.03 11.92 10.75
Income Quality
0.62 0.89 0.92 0.87 0.92
Currency in AUD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis